ORCID Profile
0000-0002-2556-2371
Current Organisations
European Airway Management Society (EAMS) (doi.org/10.1016/j.tacc.2016.12.001)
,
Cento de Simulación de la Comunidad de Madrid (IDEhA) - AnestesiaR
,
Grupo Hospitalario Quirónsalud. Complejo Hospitalario Ruber Juan Bravo. Hospital Quirón San Camilo.
,
Gobierno de España Ministerio de Sanidad Servicios Sociales e Igualdad
,
Hospital Universitario Infanta Leonor
,
Universidad Católica de Valencia San Vicente Mártir
,
Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor (SEDAR)
,
Sociedad Española de Anestesia, Reanimación y Dolor (SEDAR)
,
Revista de la Sociedad Española de Anestesia y Reanimación (REDAR) - ISSN: 0034-9356
,
Universidad de Alcalá de Henares Facultad de Medicina y Ciencias de la Salud
,
Universidad Complutense de Madrid
,
Universidad CEU Cardenal Herrera
,
Universidad Politécnica de Madrid
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: SciELO Espana/Repisalud
Date: 03-2004
DOI: 10.4321/S0212-71992004000300009
Abstract: Kikuchi-Fujimoto disease or necrotizing histiocytic lymphadenitis is a self-limited process of lymphatic system that affects more frequently young women. Fever and adenopathy, often cervical, are typical. Diagnosis is fundamentally based on the affected lymph node biopsy, since laboratory data are often normal. It's a very rare entity in Spain, being more frequent in Oriental countries. It's a benign evolution process, with a spontaneous healing in some weeks or months. This is the reason because of this disease could be infradiagnosed. It's very important the differential diagnosis with malignant lymphomas, because Kikuchi-Fujimoto disease doesn't need any treatment.
Publisher: Elsevier BV
Date: 09-2016
DOI: 10.1016/J.BJAN.2015.02.002
Abstract: The goal directed hemodynamic therapy is an approach focused on the use of cardiac output and related parameters as end-points for fluids and drugs to optimize tissue perfusion and oxygen delivery. Primary aim: To determine the effects of intraoperative goal directed hemodynamic therapy on postoperative complications rates. A meta-analysis was carried out of the effects of goal directed hemodynamic therapy in adult noncardiac surgery on postoperative complications and mortality using Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. A systematic search was performed in Medline PubMed, Embase, and the Cochrane Library (last update, October 2014). Inclusion criteria were randomized clinical trials in which intraoperative goal directed hemodynamic therapy was compared to conventional fluid management in noncardiac surgery. Exclusion criteria were trauma and pediatric surgery studies and that using pulmonary artery catheter. End-points were postoperative complications (primary) and mortality (secondary). Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by type of monitor, therapy, and hemodynamic goal), and predefined sensitivity analysis. 51 RCTs were initially identified, 24 fulfilling the inclusion criteria. 5 randomized clinical trials were added by manual search, resulting in 29 randomized clinical trials in the final analysis, including 2654 patients. A significant reduction in complications for goal directed hemodynamic therapy was observed (RR: 0.70, 95% CI: 0.62-0.79, p<0.001). No significant decrease in mortality was achieved (RR: 0.76, 95% CI: 0.45-1.28, p=0.30). Quality sensitive analyses confirmed the main overall results. Intraoperative goal directed hemodynamic therapy with minimally invasive monitoring decreases postoperative complications in noncardiac surgery, although it was not able to show a significant decrease in mortality rate.
Publisher: Unpublished
Date: 2015
Publisher: SciTech Solutions
Date: 08-01-2018
Abstract: Background: The King Vision Video Laryngoscope is a relatively new device that has been incorporated in our daily surgical practice, intensive care unit, and remote areas. It has become one of the main alternatives to the rescue of a failed intubation, a tool to manage patients with difficult intubation predictors, and the first choice in ventilate and not-intubate situations.Case Presentation: In this case report, we present the management of two difficult airway cases: one in an induced patient and the other in an anticipated patient, according to the Canadian Airway Focus Group difficult airway recommendations.Conclusion: The King Vision Video Laryngoscope is effective in most adult patients and can be used with a mouth opening of at least 13 mm. Even is an effective dispositive, it has yet to show results in the management both conventional airway both difficult airway in routine clinical practice.
Publisher: Elsevier BV
Date: 08-2016
DOI: 10.1016/J.REDAR.2015.07.009
Abstract: Numerous studies have compared perioperative esophageal doppler monitoring (EDM) guided intravascular volume replacement strategies with conventional clinical volume replacement in surgical patients. The use of the EDM within hemodynamic algorithms is called 'goal directed hemodynamic therapy' (GDHT). Meta-analysis of the effects of EDM guided GDHT in adult non-cardiac surgery on postoperative complications and mortality using PRISMA methodology. A systematic search was performed in Medline, PubMed, EMBASE, and the Cochrane Library (last update, March 2015). Randomized clinical trials (RCTs) in which perioperative GDHT was compared to other fluid management. Overall complications. Mortality number of patients with complications cardiac, renal and infectious complications incidence of ileus. Studies were subjected to quantifiable analysis, pre-defined subgroup analysis (stratified by surgery, type of comparator and risk) pre-defined sensitivity analysis and trial sequential analysis (TSA). Fifty six RCTs were initially identified, 15 fulfilling the inclusion criteria, including 1,368 patients. A significant reduction was observed in overall complications associated with GDHT compared to other fluid therapy (RR=0.75 95%CI: 0.63-0.89 P=0.0009) in colorectal, urological and high-risk surgery compared to conventional fluid therapy. No differences were found in secondary outcomes, neither in other subgroups. The impact on preventing the development of complications in patients using EDM is high, causing a relative risk reduction (RRR) of 50% for a number needed to treat (NNT)=6. GDHT guided by EDM decreases postoperative complications, especially in patients undergoing colorectal surgery and high-risk surgery. However, no differences versus restrictive fluid therapy and in intermediate-risk patients were found.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 06-2014
Publisher: Elsevier BV
Date: 09-2016
DOI: 10.1016/J.BJANE.2015.02.001
Abstract: The goal directed hemodynamic therapy is an approach focused on the use of cardiac output and related parameters as end-points for fluids and drugs to optimize tissue perfusion and oxygen delivery. Primary aim: To determine the effects of intraoperative goal directed hemodynamic therapy on postoperative complications rates. A meta-analysis was carried out of the effects of goal directed hemodynamic therapy in adult noncardiac surgery on postoperative complications and mortality using Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. A systematic search was performed in Medline PubMed, Embase, and the Cochrane Library (last update, October 2014). Inclusion criteria were randomized clinical trials in which intraoperative goal directed hemodynamic therapy was compared to conventional fluid management in noncardiac surgery. Exclusion criteria were trauma and pediatric surgery studies and that using pulmonary artery catheter. End-points were postoperative complications (primary) and mortality (secondary). Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by type of monitor, therapy, and hemodynamic goal), and predefined sensitivity analysis. 51 RCTs were initially identified, 24 fulfilling the inclusion criteria. 5 randomized clinical trials were added by manual search, resulting in 29 randomized clinical trials in the final analysis, including 2654 patients. A significant reduction in complications for goal directed hemodynamic therapy was observed (RR: 0.70, 95% CI: 0.62-0.79, p<0.001). No significant decrease in mortality was achieved (RR: 0.76, 95% CI: 0.45-1.28, p=0.30). Quality sensitive analyses confirmed the main overall results. Intraoperative goal directed hemodynamic therapy with minimally invasive monitoring decreases postoperative complications in noncardiac surgery, although it was not able to show a significant decrease in mortality rate.
Publisher: Elsevier BV
Date: 08-2016
Publisher: InTech
Date: 31-01-2018
Publisher: Public Library of Science (PLoS)
Date: 28-03-2016
Publisher: Elsevier BV
Date: 02-2016
DOI: 10.1016/J.JCLINANE.2015.08.004
Abstract: Goal-directed fluid therapy (GDHT) has been proposed as a method to reduce complications and mortality. Meta-analysis of the effects of perioperative GDHT in adult noncardiac surgery on mortality and postoperative complications was performed using the PRISMA methodology. A systematic search was performed in MEDLINE, PubMed, EMBASE, and the Cochrane Library (last update, October 2014). Inclusion criteria were as follows: randomized clinical trials (RCTs) in which perioperative GDHT was compared with conventional fluid management in noncardiac surgery. Exclusion criteria were as follows: trauma and pediatric surgery studies. End points were mortality and number of patients with complications. District general hospital. Thirty-nine RCTs were initially identified, with 8 fulfilling the inclusion criteria. Two RCTs were added by manual search, resulting in 10 RCTs in the final analysis, including 1527 patients. Those studies that fulfilled the entry criteria were examined in full and subjected to quantifiable analysis, predefined subgroup analysis (stratified by supraphysiological or physiological hemodynamic goal and by time the intervention was carried out, perioperative or postoperative), and predefined sensitivity analysis. A significant reduction was observed in mortality associated with GDHT compared with conventional fluid therapy (risk ratio, 0.63 95% confidence interval, 0.42-0.94 P = .02). However, no differences were found in the number of patients with complications (risk ratio, 0.75 95% confidence interval, 0.50-1.17 P = .21), and the sensitivity analysis did not confirm the results. This meta-analysis, with its limitations, shows that the use of perioperative GDHT may reduce postoperative mortality, but it is unable to show a reduction in the number of patients with complications.
Publisher: Unpublished
Date: 2015
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2016
Publisher: Unpublished
Date: 2015
Publisher: Society for Healthcare & Research Development
Date: 12-2016
Publisher: Instituto Aragonés de Ciencias de la Salud
Date: 2014
Publisher: Medknow
Date: 2016
Publisher: Springer Science and Business Media LLC
Date: 24-04-2015
Publisher: Unpublished
Date: 2015
Publisher: Unpublished
Date: 2015
Publisher: Wiley
Date: 11-11-2015
DOI: 10.1111/ANAE.13277
Abstract: We reviewed systematically sugammadex vs neostigmine for reversing neuromuscular blockade. We included 17 randomised controlled trials with 1553 participants. Sugammadex reduced all signs of residual postoperative paralysis, relative risk (95% CI) 0.46 (0.29-0.71), p = 0.0004 and minor respiratory events, relative risk (95% CI) 0.51 (0.32-0.80), p = 0.0034. There was no difference in critical respiratory events, relative risk (95% CI) 0.13 (0.02-1.06), p = 0.06. Sugammadex reduced drug-related side-effects, relative risk (95% CI) 0.72 (0.54-0.95), p = 0.02. There was no difference in the rate of postoperative nausea or the rate of postoperative vomiting, relative risk (95% CI) 0.94 (0.79-1.13), p = 0.53, and 0.87 (0.65-1.17), p = 0.36 respectively.
Publisher: Unpublished
Date: 2015
Publisher: Unpublished
Date: 2015
Publisher: Symbiosis Group
Date: 31-08-2017
Publisher: ACM
Date: 02-11-2016
Publisher: Unpublished
Date: 2015
Publisher: Symbiosis Group
Date: 05-09-2017
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 09-2016
Location: Spain
Location: Spain
Location: Spain
Location: Spain
Location: Spain
Location: Spain
Location: Spain
Location: Spain
No related grants have been discovered for Eugenio Martinez-Hurtado.